A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

NCT06462118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Astegolimab

Sponsor

Genentech, Inc.